Evidence map›Paper›PMID 32009328›Full record

ArticleAllergy, asthma & immunology research2020

Primary Nasal Epithelial Cells From Allergic and Non-allergic Individuals Show Comparable Barrier Function.

Eva E Waltl, Victoria Stanek, Christian A Mueller, Renata Kiss, Julia Eckl-Dorna, Rudolf Valenta, Verena Niederberger

Abstract read
In one paragraph

Article in Allergy, asthma & immunology research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. FOXP1 exacerbates allergic rhinitis progression by mediating ferroptosis in nasal mucosal epithelial cells via transcriptional regulation of SDHAF2.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eva E WaltlDepartment of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria.
Victoria StanekDepartment of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria.
Christian A MuellerDepartment of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-6172-5417
Renata KissDepartment of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Julia Eckl-DornaDepartment of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-5981-1607
Rudolf ValentaDepartment of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-5944-3365
Verena NiederbergerDepartment of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria. verena.niederberger@meduniwien.ac.at.

Funding

Austrian Science Fund FWF F 4605FWFFWF DK W 1248-B13FWF SFB 4605/4613Government of the Russian Federation 14.W03.31.0024
6 · The paper itself

Abstract

Previous reports suggested that ex vivo cultured primary nasal epithelial cells from allergic patients differ from those from non-allergic individuals by genuinely reduced barrier function. By contrast, we found that primary nasal epithelial cells from allergic and non-allergic individuals showed comparable barrier function and secretion of cytokines.

Indexed as

allergenallergen-microarrayallergic rhinitisimmunoglobulin ERespiratory epithelial barrier functiontransepithelial resistance

Identifiers

PMID32009328
PMCPMC6997283

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.